Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jonathan Wiesen (NPI 1912149006)

Field	Value
Entity Type	Individual
Organization	Jonathan Wiesen
Address	600 Gresham Dr Ste 8630b
City	Norfolk
State	VA
ZIP	23507
Taxonomy	Internal Medicine Physician
NPI Enumerated	April 3, 2009

Payer Source	Total Paid
Medicare	$2.4M
Medicaid	$0

Key Findings

This provider's Medicare revenue is highly concentrated: the precomputed top 3 Medicare codes by revenue account for 95.8% of this provider's total Medicare revenue, with total Medicare revenue reported as $2.4M. That concentration indicates a narrow service mix where a very small set of administered drugs drives the vast majority of dollars billed to Medicare.

The code mix shows an operational focus on in-office administration of high-cost biologic and specialty injectable therapies rather than broad primary care E/M services. The top codes are J3245, J1306, and J2356, which are all injectable biologic or specialty agents, and the presence of multiple high-volume J-codes suggests the practice operates as an infusion/injection service line or specialty biologics administration site within an Internal Medicine taxonomy.

J3245 is the single dominant revenue generator, with 14.5K claims and $1.6M revenue representing 65.9% of the provider's Medicare revenue; nationally this provider ranks #4 of 225 and is labeled an extreme outlier (99th percentile). This indicates unusually large-scale administration of tildrakizumab relative to peers and positions the provider as a major national node for this specific drug.

J1306 shows a contrasting pattern: it has very high claim volume at 55.2K claims but a low average paid/claim ($9 avg paid/claim) yielding $497.1K in revenue and 21.1% of Medicare revenue; the provider ranks #12 of 462 nationally (98th percentile) and is described as notably above typical national volume. The disparity between claim count and avg paid/claim suggests billing of many low-dollar units of inclisiran rather than a smaller number of high-value administrations.

J2356 contributes $208.7K (8.9% of Medicare revenue) with 14.9K claims and ranks #40 of 113 (64th percentile), a profile characterized as typical and unremarkable relative to national peers. While it is part of the top three revenue drivers, J2356's rank and percentile suggest this code is not the source of the provider's national outlier status and is a secondary stabilizing revenue stream.

Outside the top three, other administered drugs and chemotherapy administration codes appear only at modest scale: examples include J3032 (2.5K claims, $32.5K revenue), 96401 (450 claims, $29.7K revenue), and J0897 (1.3K claims, $22.4K revenue), each representing small shares of the $2.4M total. These smaller volumes reinforce that the business model is concentrated on a few biologic injectables rather than a broad portfolio of infusion or E/M services.

Payer mix is effectively single-payer in practice: Medicare revenue is $2.4M while there is no Medicaid billing on file. This lack of Medicaid activity means analysts should treat the provider as operating primarily within the Medicare market and not rely on Medicaid data to characterize service mix or access patterns.

The provider's NPI was enumerated on 2009-04-03 (~17 years ago), indicating a long-tenured billing history; combined with the concentrated biologics mix and national outlier rankings for specific J-codes, this tenure is consistent with an established practice that has specialized into high-volume biologic administration over time. For payers and competitors, this suggests predictable, entrenched volume for certain specialty drugs that may warrant focused network or utilization management strategies.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

10 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3245	Injection, tildrakizumab, 1 mg	14,500	$110	$1.6M
J1306	Injection, inclisiran, 1 mg	55,240	$10	$497.1K
J2356	Injection, tezepelumab-ekko, 1 mg	14,910	$10	$208.7K
J3032	Injection, eptinezumab-jjmr, 1 mg	2,500	$10	$32.5K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	450	$70	$29.7K
J0897	Injection, denosumab, 1 mg	1,320	$20	$22.4K
99291	Critical care services include the treatment of vital organ failure or prevention of further life–threatening conditions. Delivering medical care in a moment of crisis and in time of emergency is…	30	$170	$5.6K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	30	$120	$3.9K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	50	$60	$2.9K
96372	A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician…	80	$10	$940

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 10 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Virginia Distribution

Jonathan Wiesen — 2 of 10 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Virginia

Full comparison — all codes billed, vs. state median

10 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3245	1	10	4,700	$110	$728K
J1306	1	10	13,650	$10	$225K
J2356	2	10	9,560	$10	$201.2K
J0897	283	340	2,820	$20	$89.3K
J3032	3	10	5,700	$10	$68K
96413	198	230	250	$100	$28.5K
99291	1,226	1,950	50	$170	$12.2K
96401	18	180	110	$60	$11.5K
96365	166	220	100	$50	$6.5K
96372	532	1,380	60	$10	$1.1K

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jonathan Wiesen, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Carolinas Medical Center	NC	General Acute Care Hospital	$0	$178.2M
Ohiohealth Corporation	OH	Family Medicine Physician	$0	$89.1M
Carolinas Medical Center	NC	Surgical Critical Care Physician	$0	$52.9M
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Sentara Medical Group	VA	Family Medicine Physician	$0	$48.7M
Alliance Physicians Inc	OH	Family Medicine Physician	$0	$38.9M
Mercy Health Youngstown LLC	OH	General Acute Care Hospital	$0	$36.6M
Carolinas Physicians Network Inc	NC	Psychologist	$0	$29.4M
Carolinas Medical Center	NC	Psychiatric Hospital Unit	$0	$20.6M
Carolinas Medical Center	NC	Pediatrics Physician	$0	$17.8M

Nearby Providers

Other providers in the same ZIP code as Jonathan Wiesen, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Childrens Hospital Of The Kings Daughters Inc	VA	Children's Hospital	$0	$288.2M
Sentara Hospitals	VA	General Acute Care Hospital	$0	$88M
Childrens Specialty Group PLLC	VA	Pediatrics Physician	$0	$87.7M
Sentara Reference Lab Solutions, LLC	VA	Clinical Medical Laboratory	$12.9M	$4.7M
Medical Center Radiologists Inc	VA	Diagnostic Radiology Physician	$0	$13.7M
Childrens Hospital Of The Kings Daughters Inc	VA	Adolescent and Children Mental Health Clinic/Center	$0	$10.2M
Childrens Hospital Of The Kings Daughters Inc	VA	Pediatrics Physician	$0	$8.4M
Deepak Deshmukh	VA	Vascular Surgery Physician	$1.4M	$0
Sentara Hospitals	VA	Air Ambulance	$977.3K	$170.6K
Edwin Crandley	VA	Radiation Oncology Physician	$315.3K	$0

Jonathan Wiesen — Billing Profile & Reimbursement Data

Sign up for Jonathan Wiesen — Billing Profile & Reimbursement Data policy alerts

Jonathan Wiesen — Billing Profile & Reimbursement Data

Sign up for Jonathan Wiesen — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References